NEW HAMPTON, N.Y., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Balchem Corporation (Nasdaq:BCPC) today announced that its SensoryEffects business segment will make a multi-million dollar investment in agglomeration technology and production equipment to complement its market leading capabilities in drying and blending of emulsified powders for various markets.
Commenting on the project, Jim Holdrieth, Vice President and General Manager SensoryEffects Ingredient Solutions stated, "We are very pleased to announce this strategic growth initiative. This investment in agglomeration technology will enable SensoryEffects to better serve our existing and prospective customers, as we broaden our technology and create a low cost, 'one stop shop' for high quality finished powder solutions. The agglomeration project is expected to be operational by the fourth quarter of 2015."
About Balchem
Balchem Corporation consists of three business segments: ARC Specialty Products; SensoryEffects (formerly Food, Pharma & Nutrition); and Animal Nutrition & Health. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The SensoryEffects segment provides customized food and beverage ingredient systems and proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets and certain derivative products into industrial applications.
Forward-Looking Statements
This release contains forward-looking statements, which reflect Balchem's expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem's expectations, including risks and factors identified in Balchem's annual report on Form 10-K for the year ended December 31, 2013. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.